Clinical

Dataset Information

0

Fludeoxyglucose F 18 PET Imaging in Determining Protein and Gene Expression Signatures in Patients With Premalignant Polyps or Colon Cancer


ABSTRACT: RATIONALE: Diagnostic imaging procedures, such as fludeoxyglucose F 18 PET, may be effective in detecting cancer or recurrence of cancer, or premalignant polyps. PURPOSE: This clinical trial is studying fludeoxyglucose F 18-PET imaging to see how well it works in determining protein and gene expression signatures in patients with premalignant polyps or colon cancer.

DISEASE(S): Colon Cancer,Colorectal Cancer,Neoplasm Of Uncertain Malignant Potential,Precancerous Conditions

PROVIDER: 2045806 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2041940 | ecrin-mdr-crc
| phs001784 | dbGaP
2014-04-12 | E-GEOD-56759 | biostudies-arrayexpress
| PRJEB28577 | ENA
2014-07-03 | E-GEOD-49155 | biostudies-arrayexpress
2014-03-07 | E-GEOD-43168 | biostudies-arrayexpress
2017-01-23 | E-MTAB-5255 | biostudies-arrayexpress
2016-05-25 | GSE81819 | GEO
| PRJNA209292 | ENA
2013-10-11 | E-GEOD-50431 | biostudies-arrayexpress